Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products

被引：5

作者：

Pergolizzi, Joseph V. ^{[1
,2
,3
,4
]}

Gharibo, Christopher G. ^{[5
]}

Gudin, Jeffrey A. ^{[6
]}

Nalamachu, Srinivas R. ^{[7
]}

机构：

[1] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA

[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA

[3] Georgetown Univ, Sch Med, Dept Anesthesiol, Washington, DC USA

[4] Naples Anesthesia & Pain Associates, Naples, FL USA

[5] NYU Langone Hosp Joint Dis, Dept Anesthesiol & Orthoped, New York, NY USA

[6] Englewood Hosp & Med Ctr, Englewood, NJ USA

[7] Int Clin Res Inst, Overland Pk, KS USA

来源：

关键词：

UNITED-STATES; OPIOID ANALGESICS; DIVERSION; PAIN; DEATHS; OVERDOSE; ABUSE;

D O I：

10.1111/papr.12040

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：259 / 263

页数：5

共 4 条